Mobile App to Promote Family Caregiver Engagement in the Intensive Care Unit
NCT ID: NCT05157919
Last Updated: 2024-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2020-01-06
2022-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rounding Summaries for Families of Critically Ill Patients
NCT03969810
The Efficacy of Nurse-driven, Protocol Guided Ventilator Weaning in a Medical-Surgical Intensive Care Unit (ICU)
NCT00786617
Brain Computer Interface for Communication in Ventilated Patients
NCT02791425
Smartphone Application for Initiation of Protective Ventilation. Clinical Impact of Instrumental Dead Space Reduction
NCT04390360
Family-Initiated Interpretation in the PICU
NCT05791240
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Usual care continues. The caregiver will not get to use the app. The caregiver will be asked daily measures and the patient will be asked about thirst and anxiety daily when the patient is awake enough to answer these questions. The caregiver will be asked questions at 3 different times: Day 1, 24-48 hours after enrollment, and 2-4 weeks after the patient is discharged from the ICU.
No interventions assigned to this group
Intervention with App
The caregiver gets access to use the app. Each day, investigators will ask the patient to rate their thirst and anxiety and the caregiver to answer daily measures through the application. The caregiver will be asked questions at 3 different times: Day 1, 24-48 hours after enrollment, and 2-4 weeks after the patient is discharged from the ICU. The caregiver will be taught how to use the app. The caregiver will be given the supplies that the caregiver needs to perform the symptom management intervention. Investigators will ask the caregiver to use the app at least once a day, but the caregiver can use it as much as desired while the patient is in the ICU.
ICU-Care
The mobile app intervention, ICU-CARE, will consist of 3 separate education modules, each approximately 5-7 minutes in length: (Module #1) ICU orientation, (Module #2) Symptom Assessment, (Module #3) Symptom Management
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ICU-Care
The mobile app intervention, ICU-CARE, will consist of 3 separate education modules, each approximately 5-7 minutes in length: (Module #1) ICU orientation, (Module #2) Symptom Assessment, (Module #3) Symptom Management
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 19 or older
* Able to understand English
* Able and willing to use the hospital-provided tablet devices
* Can view images on a screen and hear audio through a standard headset
* Have basic reading skills and the ability to read aloud
Critically ill patients in the ICU who are:
* Age 19 or older
* Mechanically ventilated
* Expected to require\> 72 consecutive hours of mechanical ventilation during their ICU stay
* Calm, cooperative (a Richmond Agitation-Sedation Scale score between -5 and +1)
* Able to reliably report symptoms of thirst and anxiety per nursing assessment
* Have no documented hearing deficits
* Have a designated caregiver who visits frequently (daily for a minimum of 1 hour)
Exclusion Criteria
* Caregivers of patients who are not currently undergoing mechanical ventilation
* Caregivers of patients who are not calm, cooperative (a Richmond Agitation- - Sedation Scale score between +2 and +4),
* Caregivers of patients who cannot reliably report symptoms of thirst and anxiety
* Caregivers of patients who have a documented hearing deficit.
* Caregivers who do not visit the patient frequently (at least once per day for a minimum of 1 hour as described by nursing staff)
Critically ill patients in the ICU who are:
* Recovering from any of the following surgeries: Glossectomy, Maxillectomy, Neck Dissection, Facial/neck flap
* Receiving aggressive ventilator support such as positive end expiratory pressure\> 15cm of water, prone ventilation
* Not alert per nursing assessment (Richmond Agitation-Sedation Scale Score +2 or greater)
* Severe cognition or communication problems (i.e. coma as the main reason for intubation, dementia, severe delirium)
* Deafness
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Nebraska
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Breanna D Hetland, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Nebraska
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nebraska Medicine
Omaha, Nebraska, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0625-17-EP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.